SLSN
SOLESENCE, INC.
$1.21
-3.97%
$89.0M
No data for this timeframe.
Vol
Market Cap$89.0M
Cap SizeMicro Cap
Inst. Holders6 funds
Inst. Value$1.9M
Inst. Activity4 buys / 0 sells
SEC Reports5
Press Releases2
Exchange Nasdaq·Sector Perfumes, Cosmetics & Other Toilet Preparations·Inc. DE·CIK 0000883107·Prev Close $1.26
Recent Activity
May 12, 2026
SEC
Solsence reported Q1 2026 revenue of $13.0M, down 11.4% YoY from $14.6M, and posted a net loss of $0.8M versus a net inc
8-K — Impact 6/10
May 12, 2026
SEC
Solésence reported Q1 2026 revenue of $12.96M, down 11.4% YoY from $14.63M, and swung to a net loss of $0.77M from net i
PRESS-RELEASE — Impact 6/10
Apr 28, 2026
SEC
Solésence announced the date for its Q1 2026 earnings release and conference call on May 12, 2026. No financial results
PRESS-RELEASE — Impact 2/10
Inst.
MORGAN STANLEY — DOUBLED
35,288 shares ($56.3K)
Inst.
WELLS FARGO & COMPANY/MN — ADD
20,773 shares ($33.1K)
May 19, 2026
routine
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
<p align="center"> <em> SPF-Infused Concealer Featuring Kleair™</em>,<em> WHSPR™</em>,<em> and
Mar 31, 2026
Press
Solésence reported record full-year 2025 revenue of $62.1 million, up 19% YoY, but full-year net income declined 58% to
Impact 5/10
Mar 19, 2026
Press
Solésence, Inc. announced it will report its fourth quarter and full-year 2025 earnings on March 31, 2026, before market
Impact 3/10
Latest Reports
BEARISH
8-K
6/10
Solsence reported Q1 2026 revenue of $13.0M, down 11.4% YoY from $14.6M, and posted a net loss of $0.8M versus a net inc
May 12, 2026
BEARISH
PRESS-RELEASE
6/10
Solésence reported Q1 2026 revenue of $12.96M, down 11.4% YoY from $14.63M, and swung to a net loss of $0.77M from net i
May 12, 2026
MIXED
Press
5/10
Solésence reported record full-year 2025 revenue of $62.1 million, up 19% YoY, but full-year net income declined 58% to
Mar 31, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| VANGUARD GROUP INC | $1.7M | NEW |
| CHARLES SCHWAB INVESTMENT MANAGEMENT | $75.6K | NEW |
| MORGAN STANLEY | $56.3K | DOUBLED |
| WELLS FARGO & COMPANY/MN | $33.1K | ADD |
| BANK OF AMERICA CORP | $18.6K | DOUBLED |
6 institutional holders with $1.9M total value (1,164,421 shares) as of 2025-Q4. Top holders: VANGUARD, CHARLES, MORGAN. Net buying activity: 4 institutions added/increased vs 0 reduced.
Top Institutional Holders — 2025-Q4
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | VANGUARD GROUP INC | 1,048,394 | $1.7M | 90.0% | NEW |
| 2 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 47,387 | $75.6K | 4.1% | NEW |
| 3 | MORGAN STANLEY | 35,288 | $56.3K | 3.0% | DOUBLED +123.5% |
| 4 | WELLS FARGO & COMPANY/MN | 20,773 | $33.1K | 1.8% | ADD +48.9% |
| 5 | BANK OF AMERICA CORP /DE/ | 11,657 | $18.6K | 1.0% | DOUBLED +111.5% |
| 6 | FMR LLC | 922 | $1.5K | 0.1% | DOUBLED +674.8% |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| MORGAN STANLEY | DOUBLED | 15,791 | 35,288 | +123.5% | $56.3K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 13,954 | 20,773 | +48.9% | $33.1K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | DOUBLED | 5,511 | 11,657 | +111.5% | $18.6K | 2025-Q4 |
| FMR LLC | DOUBLED | 119 | 922 | +674.8% | $1.5K | 2025-Q4 |
| UBS Group AG | ADD | 12,239 | 19,050 | +55.6% | $61.3K | 2025-Q3 |
| MORGAN STANLEY | TRIM | 32,824 | 15,791 | -51.9% | $50.8K | 2025-Q3 |
| VANGUARD GROUP INC | NEW | — | 940,848 | — | $4.1M | 2025-Q2 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | NEW | — | 47,387 | — | $206.6K | 2025-Q2 |
| MORGAN STANLEY | NEW | — | 32,824 | — | $143.1K | 2025-Q2 |
| UBS Group AG | NEW | — | 12,239 | — | $53.4K | 2025-Q2 |
| WELLS FARGO & COMPANY/MN | NEW | — | 12,120 | — | $52.8K | 2025-Q2 |
| BANK OF AMERICA CORP /DE/ | NEW | — | 6,028 | — | $26.3K | 2025-Q2 |
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
5 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 1 mixed, 2 neutral. Avg impact: 4.6/10.
BEARISH
8-K
6/10
Solsence reported Q1 2026 revenue of $13.0M, down 11.4% YoY from $14.6M, and posted a net loss of $0
May 12, 2026
BEARISH
PRESS-RELEASE
6/10
Solésence reported Q1 2026 revenue of $12.96M, down 11.4% YoY from $14.63M, and swung to a net loss
May 12, 2026
NEUTRAL
PRESS-RELEASE
2/10
Solésence announced the date for its Q1 2026 earnings release and conference call on May 12, 2026. N
Apr 28, 2026
NEUTRAL
10-K/A
3/10
SOLESENCE, INC. filed an amended 10-K to add Exhibit 97.1, its new Clawback Policy, which was inadve
Apr 23, 2026
MIXED
8-K
6/10
Solsence reported full-year 2025 record revenue of $62.1 million, up 19% YoY, but net income decline
Apr 21, 2026
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2024-12-31 |
$0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next FY | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 19, 2026
routine
Solésence Day Mode Hero Concealer SPF 50+ Wins Three Categories at the 2026 Cosmetics & Toiletries Allē Awards, Marking Fourth Year of Recognition
<p align="center"> <em> SPF-Infused Concealer Featuring Kleair™</em>,<em> WHSPR™</em>,<em> and Chromalüm™ Recognized Across <br>Anti-Aging, Color
May 14, 2026
other
Solésence Supports Landmark Report on UV Safety in the United Kingdom as Member of UV Safety Coalition
<p align="center"><em>The report, led by the United Kingdom’s APPG for Beauty, Hair & Wellbeing, calls for a national strategy to combat UV exposu
May 12, 2026
earnings
Solésence Reports First Quarter 2026 Financial Results
<p align="center"><em>Advances implementation of Transform and Transcend strategic initiative across Operational Excellence and New Technology Commerc
May 12, 2026
earnings_calendar
SLSN Q1 2026 Earnings Scheduled — 2026-05-12
May 11, 2026
other
Solésence Launches New Skin Health Technologies: WHSPR™ and Chromalüm™
<p align="center"><em>New platform technologies enable OTC-grade sensitive skin claims in previously inaccessible anhydrous formats and bring environm
May 4, 2026
earnings_calendar
SLSN Q1 2026 Earnings Scheduled — 2026-05-04
Apr 28, 2026
earnings
Solésence To Report First Quarter 2026 Financial Results and Host a Conference Call on May 12
<p>ROMEOVILLE, Ill., April 28, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions acro
Apr 27, 2026
other
Solésence, Inc. Announces Appointment of New Independent Director
<p align="center"><em>Marc James to Join Board of Directors and Serve on Audit, Compensation, and Nominating Committees</em></p>
Mar 31, 2026
earnings
Solésence Reports Fourth Quarter and Full-Year 2025 Financial Results
<p align="center"><em>Full Year 2025 record revenue of $62.1 million</em></p>
Mar 31, 2026
earnings_calendar
SLSN Q4 2025 Earnings Scheduled — 2026-03-31
Mar 19, 2026
earnings
Solésence To Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call on March 31, 2026
<p align="left">ROMEOVILLE, Ill., March 19, 2026 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care s